Market revenue in 2023 | USD 262.3 million |
Market revenue in 2030 | USD 355.5 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 76.1% in 2023. Horizon Databook has segmented the Switzerland healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Switzerland is one of the most competitive and innovative research destinations globally. It is one of the most dynamic countries around the worldwide in terms of research activity.
The country invests close to 3% of its GDP in R&D. Moreover, healthcare firms prefer to conduct R&D in the country due to its highly skilled workforce, high labor productivity, and proximity to world-class research institutions.
In addition, manufacturers spend up to 30% of their revenue on R&D. Growth is also driven by collaborations, for instance, such as collaboration of Novartis and Biocon to develop biosimilars for use in oncology & immunology.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account